GV18-04

Validated Clinical Risk Score for Acute Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Study #: GV18-04

Study Status: Published

Presentation(s)

2022, ASH (Oral)

2025, EBMT (Poster)

Validated clinical risk score for acute graft-versus-host disease in adult allogeneic hematopoietic cell transplantation.

Ulschmid C, Li X, Wang T, Logan BR, Pidala JA, MacMillan ML, Kitko CL, Lee SJ, Spellman SR, Wael S.

Blood Advances. 2025, Dec 10: (): . doi: 10.1182/bloodadvances.2025016938. Epub 2025, Dec 10. PMCID:.

PMID: 41498421